Both in Pharmaceuticals
Adicet Bio vs TransCode Therapeutics
Over the past year ACET returned −72.6% and RNAZ returned −84.5%; their daily moves had a correlation of 0.06.
ACET −72.6% RNAZ −84.5%Growth of $1, one year, split-adjusted
| Metric | ACET | RNAZ |
|---|---|---|
| Price | $3.20 | $1.63 |
| Market cap | $30.0M | $27.6M |
| Today | −6.43% | 0.00% |
| 1 month | −50.8% | +3.8% |
| 6 months | −62.1% | −78.9% |
| Year to date | −62.0% | −76.1% |
| 1 year | −74.3% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $117.4M | $7.7M |
| Dividend yield | — | — |
| Volatility (60d) | 97.1% | 75.5% |
| Short % of float | 6.3% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).